Alerts will be sent to your verified email
Verify Email
ZYDUSLIFE
|
Zydus Lifesciences
|
Mankind Pharma
|
Dr. Reddy's Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Number of ANDA's Filed in USA
|
481.0 . | 67.0 . | 362.0 . |
|
Number of ANDA's Approved By USFDA
|
419.0 . | 48.0 . | 292.0 . |
|
Domestic Sales Growth - YoY
|
6.7 % | 7.9 % | 9.1 % |
|
US DMF Filings
|
147.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
7.4 % | 2.2 % | 7.3 % |
|
Financials
|
|||
|
5 yr Average ROE
|
18.47 % | 20.33 % | 15.68 % |
|
5yr average Equity Multiplier
|
1.52 | 1.46 | 1.41 |
|
5yr Average Asset Turnover Ratio
|
0.66 | 0.81 | 0.74 |
|
5yr Avg Net Profit Margin
|
19.02 % | 17.68 % | 15.18 % |
|
Price to Book
|
4.35 | 7.4 | 3.26 |
|
P/E
|
22.77 | 56.03 | 19.26 |
|
5yr Avg Cash Conversion Cycle
|
-84.89 Days | -13.08 Days | 74.48 Days |
|
Inventory Days
|
36.38 Days | 59.06 Days | 76.14 Days |
|
Days Receivable
|
36.93 Days | 34.35 Days | 95.44 Days |
|
Days Payable
|
160.15 Days | 121.69 Days | 102.6 Days |
|
5yr Average Interest Coverage Ratio
|
30.19 | 46.07 | 35.66 |
|
5yr Avg ROCE
|
19.65 % | 25.06 % | 21.82 % |
|
5yr Avg Operating Profit Margin
|
24.4 % | 24.62 % | 23.61 % |
|
5 yr average Debt to Equity
|
0.17 | 0.16 | 0.12 |
|
5yr CAGR Net Profit
|
16.23 % | 9.49 % | 23.71 % |
|
5yr Average Return on Assets
|
12.22 % | 14.46 % | 11.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.99 % | 72.68 % | 26.64 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.11 % | -3.82 % | -0.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.94 % | 5.51 % | -0.6 % |
|
Zydus Lifesciences
|
Mankind Pharma
|
Dr. Reddy's Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
Therapeutic Area Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|